Jan 8 (Reuters) - Natus Medical:
* REVENUE IN Q4 WAS LOWER THAN EXPECTED DUE TO WEAKNESS IN OUR U.S. NEURODIAGNOSTIC BUSINESS
* ‍FULL YEAR AND Q1 2018 NON-GAAP GUIDANCE DOES NOT INCLUDE EXPENSES FOR U.S. MEDICAL DEVICE TAX​
* DUE IN PART TO DISRUPTION FROM INTEGRATION OF COMPUTER SYSTEMS, Q4 REVENUE ALSO LOWER THAN EXPECTED AT OTOMETRICS
* ‍IF NOT REPEALED OR SUSPENDED, MEDICAL DEVICE TAX WILL HAVE AN ANNUAL AFTER TAX COST OF APPROXIMATELY $3.0 MILLION​
* INCREASING INVESTMENTS IN KEY PRODUCT AREAS IN 2018 * ANNOUNCES 2018 ANNUAL AND FIRST QUARTER FINANCIAL GUIDANCE
* SEES FY 2018 NON-GAAP EARNINGS PER SHARE $1.60 TO $1.65 * SEES Q1 2018 REVENUE $125 MILLION TO $127 MILLION * SEES FY 2017 REVENUE $500.5 MILLION TO $501.5 MILLION * SEES FY 2018 REVENUE $535 MILLION TO $540 MILLION * SEES Q1 2018 NON-GAAP EARNINGS PER SHARE $0.23 TO $0.24 * SEES Q4 2017 REVENUE ABOUT $131 MILLION TO $132 MILLION * EXPECT OTOSCAN REVENUES TO RAMP IN SECOND HALF OF 2018 Source text for Eikon: Further company coverage:
 